VEEA INC. 8-K

What Happened
VEEA Inc. announced that Douglas Maine, a member of the Board, audit committee and compensation committee, died on June 1, 2026. On June 2, 2026 the company notified Nasdaq that, as a result of his passing, it no longer meets Nasdaq’s independent director requirements for board composition and for its audit and compensation committees.

Key Details

• Director death: Douglas Maine passed away on June 1, 2026. The company reported his death and offered condolences.
• Board composition: The Board has six directors, of which three are independent — not a majority required under Nasdaq Listing Rule 5605(b)(1).
• Committee composition: The audit committee currently has two independent directors (needs at least three under Rule 5605(c)(2)(A)); the compensation committee has one independent director (needs at least two under Rule 5605(d)(2)(A)).
• Nasdaq cure period: Nasdaq granted a cure period until the earlier of the company’s next annual meeting of shareholders or May 31, 2027; if the next annual meeting is held before November 27, 2026, the cure deadline is November 27, 2026.
• Listing status: There is no immediate effect on VEEA’s Nasdaq listing; common stock and public warrants will continue trading under symbols VEEA and VEEAW. The company says it intends to take actions to regain compliance but offers no assurance it will meet the deadline.

Why It Matters
This filing signals a governance compliance issue that the company must fix to meet Nasdaq rules. Investors should note (1) the change was triggered by an unexpected director death, not by a business event; (2) the company has a specified period to appoint additional independent directors to restore compliance; and (3) trading is not suspended now, but prolonged noncompliance could lead to further Nasdaq action if not cured.